AG真人官方

STOCK TITAN

Artivion to Participate in Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Artivion (NYSE:AORT), a cardiac and vascular surgery company, announced its participation in two upcoming investor conferences. The company will present at the Canaccord Genuity 45th Annual Growth Conference on August 13, 2025, at 10:30 a.m. ET, with a live webcast available on their website. Additionally, management will participate in investor meetings at the 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 12, 2025, though no webcast will be available for this event.

Artivion (NYSE:AORT), azienda specializzata in chirurgia cardiaca e vascolare, ha annunciato la sua partecipazione a due prossimi convegni per investitori. La societ脿 presenter脿 al Canaccord Genuity 45th Annual Growth Conference il 13 agosto 2025 alle 10:30 ET, con una diretta web disponibile sul loro sito. Inoltre, il management parteciper脿 a incontri con investitori al 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference il 12 agosto 2025, anche se per questo evento non sar脿 disponibile alcuna diretta web.

Artivion (NYSE:AORT), una empresa de cirug铆a card铆aca y vascular, anunci贸 su participaci贸n en dos pr贸ximas conferencias para inversores. La compa帽铆a presentar谩 en la Canaccord Genuity 45th Annual Growth Conference el 13 de agosto de 2025 a las 10:30 a.m. ET, con una transmisi贸n en vivo disponible en su sitio web. Adem谩s, la direcci贸n participar谩 en reuniones con inversores en la 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference el 12 de agosto de 2025, aunque no habr谩 transmisi贸n en vivo para este evento.

Artivion (NYSE:AORT)電� 鞁灔 氚� 順堦磤 靾橃垹 須岇偓搿�, 雼り皜鞓る姅 霊� 臧滌潣 韴瀽鞛� 旎嵓霟办姢鞐� 彀胳棳頃� 鞓堨爼鞛勳潉 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 2025雲� 8鞗� 13鞚� 鞓れ爠 10鞁� 30攵�(霃欕秬鞁滉皠)鞐� Canaccord Genuity 45th Annual Growth Conference鞐愳劀 氚滍憸頃橂┌, 鞗轨偓鞚错姼鞐愳劀 靸濎瓿勱皜 鞝滉车霅╇媹雼�. 霕愴暅 瓴届榿歆勳潃 2025雲� 8鞗� 12鞚检棎 鞐措Μ電� 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference鞐愳劀 韴瀽鞛� 氙疙寘鞐� 彀胳棳頃� 鞓堨爼鞚措倶, 鞚� 頄夓偓鞐愲姅 靸濎瓿勱皜 鞝滉车霅橃 鞎婌姷雼堧嫟.

Artivion (NYSE:AORT), une entreprise sp茅cialis茅e en chirurgie cardiaque et vasculaire, a annonc茅 sa participation 脿 deux prochaines conf茅rences pour investisseurs. La soci茅t茅 pr茅sentera lors de la Canaccord Genuity 45th Annual Growth Conference le 13 ao没t 2025 脿 10h30 ET, avec une diffusion en direct disponible sur leur site web. De plus, la direction participera 脿 des r茅unions avec des investisseurs lors de la 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference le 12 ao没t 2025, bien qu鈥檃ucune diffusion en direct ne soit pr茅vue pour cet 茅v茅nement.

Artivion (NYSE:AORT), ein Unternehmen f眉r Herz- und Gef盲脽chirurgie, gab seine Teilnahme an zwei bevorstehenden Investorenkonferenzen bekannt. Das Unternehmen wird am Canaccord Genuity 45th Annual Growth Conference am 13. August 2025 um 10:30 Uhr ET pr盲sentieren, mit einem Live-Webcast auf ihrer Website. Zudem wird das Management an Investorenmeetings auf der 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference am 12. August 2025 teilnehmen, jedoch wird es f眉r diese Veranstaltung keinen Webcast geben.

Positive
  • None.
Negative
  • None.

ATLANTA, July 30, 2025 /PRNewswire/ --听Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.

Artivion's management team will present at the upcoming听Canaccord Genuity 45th Annual Growth Conference on Wednesday, August 13, 2025 at the InterContinental Boston Hotel. The Company's presentation is scheduled to begin at 10:30 a.m. ET. A live webcast can be accessed through Artivion's website, , on the Investors page.听 An archived copy of the webcast will be available for 90 days on the same website.听

Artivion management will also be participating in investor meetings at the 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 12, 2025. Due to the format of this event no webcast will be available.

About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, .

Contact:

Artivion听 听 听 听 听 听 听 听 听

Gilmartin Group LLC

Lance A. Berry

Brian Johnston / Laine Morgan

Executive Vice President &

Phone: 332-895-3222

Chief Financial Officer

[email protected]

Phone: 770-419-3355


Cision View original content to download multimedia:

SOURCE Artivion, Inc.

FAQ

When is Artivion (AORT) presenting at the Canaccord Genuity Growth Conference?

Artivion will present on Wednesday, August 13, 2025 at 10:30 a.m. ET at the InterContinental Boston Hotel.

How can investors access Artivion's Canaccord conference presentation?

Investors can access the live webcast through Artivion's website (www.artivion.com) on the Investors page. The archived webcast will be available for 90 days.

Which investor conferences will Artivion (AORT) attend in August 2025?

Artivion will attend the Canaccord Genuity 45th Annual Growth Conference on August 13 and the 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 12, 2025.

Will there be a webcast available for Artivion's Needham conference participation?

No, there will be no webcast available for the Needham Virtual MedTech & Diagnostics Conference due to its 1x1 meeting format.
Artivion, Inc.

NYSE:AORT

AORT Rankings

AORT Latest News

AORT Latest SEC Filings

AORT Stock Data

2.08B
42.17M
4.5%
89.69%
2.56%
Medical Devices
Surgical & Medical Instruments & Apparatus
United States
KENNESAW